Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-25

Clinical Trial Update: Study of Dehydrex in Patients With Corneal Erosion [NA]

View source ↗

Summary

The study of Dehydrex in patients with corneal erosion (recurrent corneal disease) has completed according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dehydrex

Snippet

Sponsor: Holles Laboratories, Inc. | Conditions: Corneal Diseases, Recurrence | NA | Status: COMPLETED